Geetha Manjunath
|
Founder and CEO
NIRAMAI |
|
Dr. Geetha Manjunath is the Founder, CEO and CTO of NIRAMAI Health Analytix, and has led the company to develop a breakthrough AI solution for detecting early stage breast cancer in a non-invasive radiation-free manner. Geetha holds a PhD from IISc and management education from Kellogg’s Chicago. She comes with over 25 years of experience in IT innovation. She has proposed and led multiple AI projects at Xerox Research and Hewlett Packard India. Before starting NIRAMAI, Geetha was a Lab Director for Data Analytics Research at Xerox India. Geetha has received many international and national recognition for her innovations and entrepreneurial work, including CSI Gold Medal, BIRAC WinER Award 2018 and is also on the Forbes List of Top 20 Self-Made Women this year. Geetha is also an inventor of 16 US patents and more pending grant. She was recently awarded the Accenture Vahini Innovator of the Year Award from Economic Times and was titled as The Woman Entrepreneur of the year 2020 by Biospectrum.
|
Keynote: AI in Healthcare: Cancer to Covid
While AI is revolutionizing several fields globally, its applications in the healthcare domain pose several challenges due to the criticality of predictions. In this talk, Geetha will share her insights from her experience of using machine learning as the core of their novel cancer-screening solution that is deployed in several hospitals in India today.
Meet-the-Speaker:
Geetha will also participate in a Meet the Speaker session, where you will be able to have a deeper dive conversation about topics covered on the main stage. Accessible to WiDS Worldwide registrants.
Geetha will also participate in a Meet the Speaker session, where you will be able to have a deeper dive conversation about topics covered on the main stage. Accessible to WiDS Worldwide registrants.